Literature DB >> 13673092

Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients.

W MANDEL, A D HEATON, W F RUSSELL, G MIDDLEBROOK.   

Abstract

Entities:  

Keywords:  ISONIAZID/in blood; STREPTOMYCIN/in blood; TUBERCULOSIS, PULMONARY/blood in

Mesh：

Substances：

Year:  1959        PMID： 13673092      PMCID： PMC442090          DOI： 10.1172/JCI103911

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

1.  Use of a serum microbiologic assay technique for estimating patterns of isoniazid metabolism.

Authors:  J C BELL; D K RIEMENSNIDER
Journal:  Am Rev Tuberc       Date:  1957-06

2.  The delayed appearance of isoniazid antagonism by pyridoxine in vivo.

Authors:  R McCUNE; K DEUSCHLE; W McDERMOTT
Journal:  Am Rev Tuberc       Date:  1957-12

3.  Inhibition of isoniazid acetylation in vitro and vivo.

Authors:  W JOHNSON; G CORTE
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

4.  Effect of para-aminosalicylic acid on serum isoniazid levels in man.

Authors:  W MANDEL; M L COHN; W F RUSSELL; G MIDDLEBROOK
Journal:  Proc Soc Exp Biol Med       Date:  1956-03

5.  Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients.

Authors:  M L COHN; W MANDEL; G MIDDLEBROOK; W F RUSSELL
Journal:  Am J Med Sci       Date:  1957-01       Impact factor: 2.378

6.  Clinical evaluation of isoniazid.

Authors:  G MIDDLEBROOK; S H DRESSLER
Journal:  Am Rev Tuberc       Date:  1954-12

7.  Effect of isoniazid on vitamin B6 metabolism; its possible significance in producing isoniazid neuritis.

Authors:  J P BIEHL; R W VILTER
Journal:  Proc Soc Exp Biol Med       Date:  1954-03

8.  Determination of blood plasma levels of hydrazine derivatives of isonicotinic acid.

Authors:  S H RUBIN; L DREKTER; J SCHEINER; E DE RITTER
Journal:  Dis Chest       Date:  1952-04

9.  Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds.

Authors:  J BERNSTEIN; W A LOTT; B A STEINBERG; H L YALE
Journal:  Am Rev Tuberc       Date:  1952-04

10.  The estimation of isonicotinic acid hydrazide (nydrazid) in biologic fluids.

Authors:  J M KELLY; R B POET
Journal:  Am Rev Tuberc       Date:  1952-04
View more
  3 in total

1.  Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis.

Authors:  W F RUSSELL; I KASS; A D HEATON; S H DRESSLER; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.

Authors:  P R GANGADHARAM; A L BHATIA; S RADHAKRISHNA; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

3.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS.

Authors:  P R GANGADHARAM; S DEVADATTA; W FOX; C N NAIR; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.